Crossmark Global Holdings Inc. increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 14.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 368,095 shares of the healthcare product maker's stock